NATOR Atenolol 50 mg film coated tablets bottle
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Patient Information leaflet
(PIL)
24-08-2020
Public Assessment Report
(PAR)
28-11-2017
Send request.
Active ingredient:
atenolol, Quantity: 50 mg
Available from:
Ipca Pharma (Australia) Pty Ltd
INN (International Name):
Atenolol
Pharmaceutical form:
Tablet, film coated
Composition:
Excipient Ingredients: magnesium carbonate hydrate; sodium starch glycollate type A; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; purified water; hypromellose; macrogol 6000; titanium dioxide; purified talc
Administration route:
Oral
Units in package:
500 tablets, 100 tablets, 250 tablets
Prescription type:
(S4) Prescription Only Medicine
Therapeutic indications:
Atenolol is indicated in the management of:,(i) All grades of hypertension, including hypertension of renal origin. (ii) Frequent disabling angina without evidence of cardiac failure. (iii) Cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) Myocardial infarction - Late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)
Product summary:
Visual Identification: Atenolol tablets 50 mg are white to off-white, circular biconvex film coated tablets with "50" embossed on one side and break line on other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Authorization status:
Registered
Authorization date:
2013-09-13
Patient Information leaflet
NATOR
CONSUMER MEDICINE INFORMATION
September 2013 / Version 1
COMMERCIAL-IN-CONFIDENCE
Ipca Pharma (Australia) Pty. Ltd-atenolol 25mg, 50mg & 100 mg film
coated tablets 2013
- 1 -
NATOR
(ATENOLOL 25MG, 50MG & 100MG FILM COATED TABLETS)
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common questions about NATOR.
It does not contain all the available information. It does not take
the place of talking to your doctor
or pharmacist.
All medicines have benefits and risks. Your doctor has weighed the
risks of you taking NATOR
against the benefits they expect it will have for you.
This medicine may also be used in emergency situations where you may
be unconscious. In this
case, this leaflet may be given to you after the medicine has been
used.
IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT NATOR IS USED FOR
NATOR belongs to a group of medicines called beta-blockers.
It works by affecting the body's response to certain nerve impulses,
especially in the heart. As a
result, it decreases the heart's need for blood and oxygen and
therefore reduces the amount of work
the heart has to do. It widens the blood vessels in the body, causing
blood pressure to fall. It also
helps the heart to beat more regularly.
NATOR is used to:
lower high blood pressure, which is called hypertension
prevent angina
treat irregular heart rhythm or beat called arrhythmias
treat heart attacks, or reduce your risk of heart complications
following a heart attack
NATOR may be either used alone or in combination with other medicines
to treat your condition.
NATOR may also be used in emergency situations or during surgery to
treat a fast heart beat before,
during or after surgery.
NATOR
CONSUMER MEDICINE INFORMATION
September 2013 / Version 1
COMMERCIAL-IN-CONFIDENCE
Ipca Pharma (Australia) Pty. Ltd-atenolol 25mg, 50mg & 100 mg film
coated tablets 2013
- 2 -
_HYPERTENSION: _
All people have blood pr
Read the complete document
